Factors important to patients' quality of life at the end of life
- PMID: 22777380
- PMCID: PMC3806298
- DOI: 10.1001/archinternmed.2012.2364
Factors important to patients' quality of life at the end of life
Abstract
Background: When curative treatments are no longer options for patients dying of cancer, the focus of care often turns from prolonging life to promoting quality of life (QOL). Few data exist on what predicts better QOL at the end of life (EOL) for advanced cancer patients. The purpose of this study was to determine the factors that most influence QOL at the EOL, thereby identifying promising targets for interventions to promote QOL at the EOL.
Methods: Coping With Cancer is a US multisite, prospective, longitudinal cohort study of 396 advanced cancer patients and their informal caregivers who were enrolled from September 1, 2002, through February 28, 2008. Patients were followed up from enrollment to death a median of 4.1 months later. Patient QOL in the last week of life was a primary outcome of Coping With Cancer and the present report.
Results: The following set of 9 factors, preceded by a sign indicating the direction of the effect and presented in rank order of importance, explained the most variance in patients' QOL at the EOL: 1 = (-) intensive care unit stays in the final week (explained 4.4% of the variance in QOL at the EOL), 2 = (-) hospital deaths (2.7%), 3 = (-) patient worry at baseline (2.7%), 4 = (+) religious prayer or meditation at baseline (2.5%), 5 = site of cancer care (1.8%), 6 = (-) feeding-tube use in the final week (1.1%), 7 = (+) pastoral care within the hospital or clinic (1.0%), 8 = (-) chemotherapy in the final week (0.8%), and 9 = (+) patient-physician therapeutic alliance at baseline (0.7%). The vast majority of the variance in QOL at the EOL, however, remained unexplained.
Conclusion: Advanced cancer patients who avoid hospitalizations and the intensive care unit, who are less worried, who pray or meditate, who are visited by a pastor in the hospital/clinic, and who feel a therapeutic alliance with their physicians have the highest QOL at the EOL.
Conflict of interest statement
Disclosure: None of the authors have relationships with any entities having financial interest in this topic.
Comment in
-
Improving patients' quality of life at the end of life: comment on "factors important to patients' quality of life at the end of life".Arch Intern Med. 2012 Aug 13;172(15):1142-4. doi: 10.1001/archinternmed.2012.3169. Arch Intern Med. 2012. PMID: 22777572 Free PMC article. No abstract available.
-
End-of-life care: where does the standard oncology care fail our patients and what do we, as oncologists, need to do differently?JAMA Intern Med. 2013 Mar 25;173(6):474-5. doi: 10.1001/jamainternmed.2013.2170. JAMA Intern Med. 2013. PMID: 23529552 No abstract available.
-
End-of-life care: where does the standard oncology care fail our patients and what do we, as oncologists, need to do differently?--reply.JAMA Intern Med. 2013 Mar 25;173(6):475. doi: 10.1001/jamainternmed.2013.2861. JAMA Intern Med. 2013. PMID: 23529553 No abstract available.
References
-
- Peppercorn JM, Smith TJ, Helft PR, et al. Toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29(6):755–60. - PubMed
-
- Institute of Medicine. Approaching Death: Improving Care at the End of Life. Washington DC: National Academy Press; 1997.
-
- Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82. - PubMed
-
- The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995;274(20):1591–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
